Development and clinical validation of a novel six-gene signature for accurately predicting the recu...
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
About this item
Full title
Author / Creator
Liu, Zaoqu , Lu, Taoyuan , Li, Jing , Wang, Libo , Xu, Kaihao , Dang, Qin , Guo, Chunguang , Liu, Long , Jiao, Dechao , Sun, Zhenqiang and Han, Xinwei
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background A large number of patients with stage II/III colorectal cancer (CRC) have a high recurrence rate after radical resection. We aimed to develop a novel tool to stratify patients with different recurrence-risk for optimizing decision-making in post-operative surveillance and therapeutic regimens. Methods We retrospectively enrolled four ind...
Alternative Titles
Full title
Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_571b01d84ac242089be63d87ea50c9be
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_571b01d84ac242089be63d87ea50c9be
Other Identifiers
ISSN
1475-2867
E-ISSN
1475-2867
DOI
10.1186/s12935-021-02070-z
